Key facts
- Ogibiotec’s last known valuation is $13.4M (Jun 2025).
- It has raised $4.8M; the latest was Early Stage VC ($2.0M) in Jun 2025.
- Notable investors include Scottish Enterprise, WCS Nominees, Old College Capital, Andrew Coleman, Apollo Informal Investment — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Ogibiotec
- ·The full record, as it builds
Funding rounds
No funding rounds for Ogibiotec are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ogibiotec
Developer of a modular culturing system intended to replicate manual flask culturing. The company's system provides a base unit and retrofittable modules that can be added or removed by the customer at any point, enabling scientists to select the measurement and control features they require for their culturing process.
- Sector
- Healthcare
- HQ
- Edinburgh, United Kingdom
- Employees
- 12
- Website
- ogibiotec.com/
- Ownership
- Privately Held (backing)
Ogibiotec doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ogibiotec shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ogibiotec in its N-PORT filings yet. We sweep new filings monthly.